Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Infection with Highly Pathogenic Avian Influenza A(H5N5) Virus.

The New England journal of medicine·2026
Same author

A whole-blood transcriptional signature associated with obstructive post-tuberculosis lung disease.

medRxiv : the preprint server for health sciences·2026
Same author

Human genetic variation associates with infection by derived Ugandan M. tuberculosis lineage.

The Journal of infectious diseases·2026
Same author

Dormancy regulon reduction was pivotal to the evolution of Mycobacterium tuberculosis.

Nature communications·2026
Same author

Socioeconomic and Behavioral Inequalities in Cardiovascular Health: Insights From a Multiethnic Asian Nation.

JACC. Asia·2026
Same author

Human iPSC-derived alveolar macrophages reveal macrophage subtype functions of itaconate in M. tuberculosis defense.

JCI insight·2026
Same journal

Reprogramming the <i>Mycobacterium tuberculosis</i> transcriptome during pathogenesis.

Drug discovery today. Disease mechanisms·2023
Same journal

New aspects of p38 mitogen activated protein kinase (MAPK) biology in lung inflammation.

Drug discovery today. Disease mechanisms·2020
Same journal

The renin-angiotensin system in acute respiratory distress syndrome.

Drug discovery today. Disease mechanisms·2020
Same journal

Editorial.

Drug discovery today. Disease mechanisms·2020
Same journal

Molecular targets for the rational design of drugs to inhibit SARS coronavirus.

Drug discovery today. Disease mechanisms·2020
Same journal

Preface.

Drug discovery today. Disease mechanisms·2015
See all related articles

Related Experiment Video

Updated: Jul 3, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Tuberculosis Infection: Insight from Immunogenomics.

Matthew Arentz1, Thomas R Hawn

  • 1Division of Pulmonary & Critical Care Medicine, Department of Medicine, University of Washington School of Medicine Seattle, WA, USA.

Drug Discovery Today. Disease Mechanisms
|August 5, 2008
PubMed
Summary
This summary is machine-generated.

Understanding the host immune response to Mycobacterium tuberculosis (MTb) infection is crucial for developing effective vaccines. Recent advances in innate immunity and immunogenetics offer new therapeutic strategies for tuberculosis.

More Related Videos

Optimized Workflow for Iterative Bleaching Extends Multiplexity Imaging of Highly Autofluorescent Clinical Samples
06:52

Optimized Workflow for Iterative Bleaching Extends Multiplexity Imaging of Highly Autofluorescent Clinical Samples

Published on: July 11, 2025

Related Experiment Videos

Last Updated: Jul 3, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Optimized Workflow for Iterative Bleaching Extends Multiplexity Imaging of Highly Autofluorescent Clinical Samples
06:52

Optimized Workflow for Iterative Bleaching Extends Multiplexity Imaging of Highly Autofluorescent Clinical Samples

Published on: July 11, 2025

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Tuberculosis (TB) remains a significant global health challenge, causing widespread illness and death.
  • A highly effective TB vaccine is urgently needed worldwide.
  • Understanding host-pathogen interactions is key to developing new interventions.

Purpose of the Study:

  • To review recent advancements in the innate immune response to Mycobacterium tuberculosis (MTb) infection.
  • To discuss novel insights from immunogenetics relevant to TB.
  • To explore potential immunomodulatory therapies for TB.

Main Methods:

  • Literature review of recent research on innate immunity in TB.
  • Analysis of current findings in immunogenetics related to MTb.
  • Synthesis of information on emerging immunomodulatory approaches.

Main Results:

  • Recent studies have deepened our understanding of the innate immune system's role in controlling MTb.
  • Immunogenetic discoveries are revealing host factors influencing TB susceptibility and progression.
  • These insights are paving the way for novel therapeutic strategies.

Conclusions:

  • Advances in innate immunity and immunogenetics are critical for TB vaccine development.
  • Targeting host responses offers promising avenues for new immunomodulatory therapies against TB.
  • Continued research is essential to combat the global burden of tuberculosis.